| Line item | 2026-03-31 FY | 2025-03-31 FY | 2024-03-31 FY | 2023-03-31 FY | 2022-03-31 FY | 2021-03-31 FY |
|---|---|---|---|---|---|---|
| Revenue | $12.64B | $12.87B | $13.67B | $14.43B | $16.27B | $17.73B |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – | – |
| R&D | – | – | – | – | – | – |
| SG&A | $1.40B | $1.35B | $1.24B | $1.38B | $1.41B | $2.07B |
| Operating Income | $970.00M | $1.02B | $1.02B | $1.16B | $1.38B | $1.10B |
| Interest Expense | $216.00M | $265.00M | $298.00M | $200.00M | $204.00M | $361.00M |
| Tax Expense | $290.00M | $234.00M | $23.00M | -$319.00M | $405.00M | $800.00M |
| Net Income | $18.00M | $389.00M | $91.00M | -$568.00M | $718.00M | -$149.00M |
| EPS (basic) | 0.1000 | 2.1500 | 0.4600 | -2.4800 | 2.8700 | -0.5900 |
| EPS (diluted) | 0.1000 | 2.1000 | 0.4600 | -2.4800 | 2.8100 | -0.5900 |
| Shares (diluted) | $178.65M | $184.92M | $198.78M | $228.99M | $255.21M | $254.14M |